IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.531
NA - Nord America 5.966
AS - Asia 4.861
SA - Sud America 885
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 2
Totale 24.325
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.859
US - Stati Uniti d'America 5.878
SG - Singapore 1.874
IE - Irlanda 1.561
CN - Cina 1.040
HK - Hong Kong 967
UA - Ucraina 793
BR - Brasile 748
GB - Regno Unito 639
IT - Italia 440
DE - Germania 433
SE - Svezia 251
VN - Vietnam 234
FI - Finlandia 218
TR - Turchia 189
KR - Corea 186
GR - Grecia 154
JP - Giappone 128
IN - India 89
FR - Francia 75
AR - Argentina 59
CA - Canada 33
AT - Austria 32
BD - Bangladesh 31
MX - Messico 31
EC - Ecuador 24
BE - Belgio 20
IQ - Iraq 20
ID - Indonesia 16
MA - Marocco 16
UZ - Uzbekistan 14
ZA - Sudafrica 14
NL - Olanda 13
EU - Europa 12
VE - Venezuela 12
CO - Colombia 11
CL - Cile 10
EG - Egitto 8
KE - Kenya 8
PK - Pakistan 8
IR - Iran 7
PE - Perù 7
ES - Italia 6
IL - Israele 6
LT - Lituania 6
PL - Polonia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
AL - Albania 5
KZ - Kazakistan 5
PA - Panama 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
MY - Malesia 4
NP - Nepal 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
SN - Senegal 3
BG - Bulgaria 2
CR - Costa Rica 2
JM - Giamaica 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 24.314
Salva come PNG Salva come JPEG
Città #
Moscow 2.671
Dublin 1.560
Jacksonville 1.201
Santa Clara 977
Hong Kong 967
Singapore 708
Chandler 707
Princeton 243
Roxbury 195
Seoul 186
New York 173
Ann Arbor 143
Cambridge 142
Beijing 128
Ashburn 122
Woodbridge 121
Boardman 115
Dallas 109
Bremen 108
Wilmington 108
Hefei 105
Medford 105
The Dalles 89
Ho Chi Minh City 82
Bengaluru 61
Jinan 56
San Mateo 55
São Paulo 54
Munich 52
Des Moines 51
Mountain View 50
Nanjing 48
Düsseldorf 45
Hanoi 42
Shenyang 42
Nuremberg 41
Naples 36
Norwalk 28
Napoli 27
Caserta 25
Belo Horizonte 21
Los Angeles 21
Brussels 20
Washington 20
Changsha 19
Zhengzhou 19
Brasília 18
Guangzhou 18
Helsinki 18
Rio de Janeiro 18
Houston 17
Lanzhou 17
Tianjin 17
Ningbo 16
Bologna 15
Campinas 15
Marano Di Napoli 14
Haikou 13
Hangzhou 13
Taizhou 13
Salvador 12
Tashkent 12
Toronto 12
Vienna 12
Baghdad 11
Guadalupe 11
Haiphong 11
Hebei 11
Nanchang 11
Porto Alegre 11
Seattle 11
Auburn Hills 10
Istanbul 10
San Francisco 10
Biên Hòa 9
Casablanca 9
Council Bluffs 9
Da Nang 9
Guayaquil 9
Rome 9
Taiyuan 9
Tokyo 9
Turku 9
Bari 8
Brooklyn 8
Dhaka 8
Goiânia 8
Mauá 8
Milan 8
Ottawa 8
Venice 8
Volvera 8
Athens 7
Fortaleza 7
Guarulhos 7
Kunming 7
Manaus 7
Quito 7
Thái Nguyên 7
Amsterdam 6
Totale 12.483
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 183
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 174
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 170
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 165
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 158
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 157
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 154
Chronic HCV infection and neurological and psychiatric disorders: an overview. 151
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 147
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 146
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 144
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 144
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 143
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 137
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 136
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 135
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 131
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 130
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 129
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 128
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 127
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 126
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 126
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 124
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 124
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 123
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 123
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 122
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 122
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 122
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19 122
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 121
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 120
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 120
Virological patterns of HCV patients with failure to interferon-free regimens. 120
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 119
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 119
HCV-related steatosis and risk of atherosclerosis 118
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 118
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 118
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 117
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 117
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 116
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 116
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 115
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 114
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 114
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 114
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 114
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 114
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 114
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 113
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 112
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 112
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 112
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 112
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 111
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 111
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 111
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 110
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 110
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 110
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 109
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 109
Viral Hepatitis C 109
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 108
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 108
Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future 108
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 108
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 107
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 107
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 107
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 106
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 105
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B 105
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 105
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 105
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 104
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 104
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 104
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 104
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 104
Decrease in HDV endemicity in Italy 103
Mild chronic hepatitis C with steatosis: Which treatment? 103
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 103
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 102
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 102
Occult HBV infection in the oncohematological setting. 102
Treatment of chronic HBV infection in developing countries. 102
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays 101
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 101
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 101
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 100
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 100
Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection 100
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 100
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 100
Management of carbapenem resistant Enterobacteriaceae infections 100
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 99
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 99
Totale 11.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021939 0 0 0 0 0 7 227 183 13 233 202 74
2021/20221.445 58 13 4 14 482 19 26 44 63 149 109 464
2022/20232.898 261 48 31 222 333 222 10 165 1.467 25 56 58
2023/20241.177 93 28 41 72 420 181 34 35 6 13 88 166
2024/20253.722 8 48 32 84 589 594 560 311 443 578 322 153
2025/202611.020 461 570 677 744 1.137 7.431 0 0 0 0 0 0
Totale 24.769